Renstrup Jens 4
4 · SpringWorks Therapeutics, Inc. · Filed Jan 11, 2021
Insider Transaction Report
Form 4
Renstrup Jens
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2021-01-07+48,600→ 48,600 totalExercise: $70.68Exp: 2031-01-07→ Common Stock (48,600 underlying) - Award
Common Stock
2021-01-07+6,075→ 250,499 total
Footnotes (2)
- [F1]Represents restricted stock awards. The restricted stock awards shall vest as follows: thirty three percent (33%) to vest on January 7, 2022, another thirty three percent (33%) to vest on January 7, 2023 and the remaining thirty four percent (34%) to vest on January 7, 2024, such that the restricted stock awards are fully vested on January 7, 2024.
- [F2]svThis option shall vest in 48 equal monthly installments subject to continued service to the Company by the Reporting Person.